Post-doctoral fellowship - Infection induced epilepsy and therapy development – University of Utah
Postdoctoral Fellow – Infection-induced model of temporal lobe epilepsy
An NIH-funded postdoctoral position is immediately available in the groups of Professors H. Steve White and Karen S. Wilcox, Pharmacology and Toxicology, at the University of Utah, to work on the project, A Novel Mouse Model of Temporal Lobe Epilepsy (R01NS065434). The overall goal of the project is to determine the role of cytokine activation in seizure generation in a viral infection model of epilepsy. The qualified postdoctoral trainee will use electrophysiological strategies coupled with molecular pharmacology techniques such as western blots, PCR, and immunohistochemistry. Successful completion of this project may reveal novel molecular targets for innovative therapeutic approaches to treat and prevent temporal lobe epilepsy. In addition, the applicant will participate in the development and implementation of animal models of epilepsy as a member of the Anticonvulsant Screening Program (ASP) (http://www.pharmacy.utah.edu/pharmtox/ADD/) and gain considerable experience in preclinical drug development.
Qualified applicants will have a Ph.D. in neuroscience, pharmacology, or a related field, and experience in electrophysiology and animal models of neurological diseases. Applicants must have excellent communication skills and enjoy working within an interdisciplinary team of neuroscientists. The scientific environment at the University of Utah is very collegial, and participation in forums like the Optogenetics Community, (http://brain.utah.edu/communities/optogenetics/index.php), and the Epilepsy journal club will broaden the successful candidate’s training. Salt Lake City, Utah, offers an excellent quality of life. From the city to the mountains to the high desert playgrounds, newcomers to Salt Lake City will find abundant cultural and recreational opportunities.
Please submit a brief statement describing prior research experience and career goals, a CV, and the contact information of three references to Karen S. Wilcox at email@example.com. Applicants from underrepresented groups are encouraged to apply. Underrepresented groups include the following: persons with disabilities, and ethnic/racial groups which are in the minority in neural sciences such as African Americans, Hispanics, Native Americans, Alaska Natives, and Pacific Islanders. Applications will be accepted until the position is filled.
For more information regarding this position, please contact:
Professor & Co-Investigator
Anticonvulsant Drug Development Program
Pharmacology & Toxicology
University of Utah
417 Wakara Way Suite 3211
Salt Lake City, UT 84108
If you are the owner of this job posting, you can enter the password you assigned to this job posting to edit the text or change the status of this listing.